Estrogens Levels and Receptors Status and Skin Tears
ESKITE
Role of Estrogens and Their Receptors in the Development of Skin Tears Evaluated in Residents of Residential Care Facilities.
1 other identifier
interventional
1,200
1 country
1
Brief Summary
Background: Skin tears (ST) or "laceration injuries" or "flap wounds" are injuries that are often found in residents of residential care facilities (RCFs). STs were first defined by Payne and Martin in 1993 as traumatic wounds, located mainly in the upper limbs, caused by "shearing, friction or mechanisms combined with the consequent separation of layers of skin. Skin Tears can cause psychological problems for the patient and represent an economic problem with important repercussions on both the patient and the community. The etiology suggests that the physiological changes of the skin related to old age, together with comorbidity, are among the main risk factors for their onset. The precise data on the phenomenon are not many, but it is estimated that STs are much more frequent than the same pressure ulcers, observing prevalence rates in RCFs around 40% Therefore, there are several risk factors hypothesized so far. Much evidence has correlated, in various physiological or pathological conditions, the role of estrogens with the functions and aging of the skin. Objectives: The project will develop on the analysis of populations of residents from RCFs belonging to the national territory. Two populations of residents cared in the RCF will be recruited. A group of subjects suffering from skin tears (group A) and a control group of subjects without skin tears (group B). The inclusion of patients in both groups will take place through a simple randomization procedure. Group A patients will be staged according to the STAR classification for skin tears. For each group a peripheral venous blood sample will be taken (to measure the levels of estrone and estradiol) and a skin biopsy will be performed in order to measure estrogen receptors (ERs) expression. A data collection sheet with angraphic and anamnestic data will be developed to correlate the demographic and comorbidity data with the clinical conditions of the patients and with the laboratory findings from the sampling. Expected results: The primary endpoint will be the correlation between serum estrogen levels, receptor expression and the presence of skin tears. The secondary endopoint will be Correlation between receptor structure and clinical staging of skin tears. Future prospectives: We believe that our study may open new frontiers in the prevention and in the management of these skin lesions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2020
CompletedFirst Posted
Study publicly available on registry
August 14, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedAugust 14, 2020
August 1, 2020
1 year
August 11, 2020
August 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation Between Estrogen and Skin Tears
The primary outcome measure will be the correlation between serum estrogen levels and skin receptor expression and skin tears onset.
at 1 year
Secondary Outcomes (1)
Correlation between patient's estrogen status and clinical staging of skin tears
at 2 years
Study Arms (2)
subjects with skin tears (Group A)
OTHERA sample of peripheral venous blood will be taken to measure the levels of estrone and estradiol. A skin biopsy on the intact skin area near the skin tear will be performed.
subjects without skin tears (Group B)
OTHERA sample of peripheral venous blood will be taken to measure the levels of estrogen. A skin biopsy (thin layer) on the intact skin area of the arm will be performed in order to evaluate skin estrogen receptors.
Interventions
a peripheral venous blood sample will be analyzed to measure the levels of estrone and estradiol. The sample of the blood sample will be deposited in the red cap tube with a polymeric gel.
in the tissues, of the related estrogenic receptors, estrogen α receptors, estrogen β receptors (ER- α, ER-β) and G protein-coupled estrogen receptor 1 (GPER) correlates with the functional status of these receptors
Eligibility Criteria
You may qualify if:
- Subjects of aged care facilities with skin tears
You may not qualify if:
- Patients who do not give consent;
- Inability of blood sampling and / or skin biopsy
- Group B
- Subjects of aged care facilities without skin tears
- Patients who do not give consent;
- Inability of blood sampling and / or skin biopsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Catanzarolead
- University of Roma La Sapienzacollaborator
Study Sites (1)
University La Sapienza of Rome
Roma, 00100, Italy
Related Publications (7)
Payne RL, Martin ML. The epidemiology and management of skin tears in older adults. Ostomy Wound Manage. 1990 Jan-Feb;26:26-37. No abstract available.
PMID: 2306325BACKGROUNDPayne RL, Martin ML. Defining and classifying skin tears: need for a common language. Ostomy Wound Manage. 1993 Jun;39(5):16-20, 22-4, 26.
PMID: 8397703BACKGROUNDLeBlanc K, Baranoski S, Christensen D, Langemo D, Sammon MA, Edwards K, Holloway S, Gloeckner M, Williams A, Sibbald RG, Regan M. International Skin Tear Advisory Panel: a tool kit to aid in the prevention, assessment, and treatment of skin tears using a Simplified Classification System (c). Adv Skin Wound Care. 2013 Oct;26(10):459-76; quiz 477-8. doi: 10.1097/01.ASW.0000434056.04071.68.
PMID: 24045566BACKGROUNDEl Safoury O, Rashid L, Ibrahim M. A study of androgen and estrogen receptors alpha, beta in skin tags. Indian J Dermatol. 2010;55(1):20-4. doi: 10.4103/0019-5154.60345.
PMID: 20418971BACKGROUNDBrincat MP, Baron YM, Galea R. Estrogens and the skin. Climacteric. 2005 Jun;8(2):110-23. doi: 10.1080/13697130500118100.
PMID: 16096167BACKGROUNDSerra R, Gallelli L, Perri P, De Francesco EM, Rigiracciolo DC, Mastroroberto P, Maggiolini M, de Franciscis S. Estrogen Receptors and Chronic Venous Disease. Eur J Vasc Endovasc Surg. 2016 Jul;52(1):114-8. doi: 10.1016/j.ejvs.2016.04.020. Epub 2016 May 21.
PMID: 27220899BACKGROUNDSerra R, Ielapi N, Barbetta A, de Franciscis S. Skin tears and risk factors assessment: a systematic review on evidence-based medicine. Int Wound J. 2018 Feb;15(1):38-42. doi: 10.1111/iwj.12815. Epub 2017 Oct 17.
PMID: 29045078BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Raffaele Serra, M.D., Ph.D.
University Magna Graecia of Catanzaro
- PRINCIPAL INVESTIGATOR
Nicola Ielapi, R.N.
University La Sapienza of Rome
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Vascular Surgery
Study Record Dates
First Submitted
August 11, 2020
First Posted
August 14, 2020
Study Start
September 1, 2020
Primary Completion
September 1, 2021
Study Completion
September 1, 2022
Last Updated
August 14, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share